Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer
- 1 May 1995
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (2) , 307-316
- https://doi.org/10.1016/0360-3016(95)00137-n
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Patterns of care and rtog studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cureInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Prostatic specific antigen confirmation of long term cure of prostate cancer treated by external beam radiation in the RTOGInternational Journal of Radiation Oncology*Biology*Physics, 1993
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- External beam radiation therapy for prostate cancer clinically confined to the glandUrology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06International Journal of Radiation Oncology*Biology*Physics, 1988
- Radical prostatectomy or radiation therapy for early prostate cancer. Two roads to the same endCancer, 1988
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic CancerJournal of Urology, 1987